Clinical Trial Update: TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled pilot trial evaluated TNF-alpha antagonists for acute exacerbations of COPD (Phase 2/3); the study was completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of COPD

Drugs mentioned

• TNF-alpha antagonists (TNF-alpha antagonist)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: COPD Exacerbation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-04-11